Granules India Ltd.

NSE: GRANULES | BSE: 532482 | ISIN: INE101D01020 | Industry: Pharmaceuticals
| Mid-range Performer
553.4000 -0.55 (-0.10%)
NSE Nov 20, 2025 09:33 AM
Volume: 31,236
 

553.40
-0.10%
GEPL Capital
Granules India is a south based, fast growing global pharmaceutical company. GIL has presence across entire pharma value chain from Active Pharmaceutical Ingredients (APIs) to Pharmaceutical Formulation Intermediaries (PFIs) to Finished Dosages (FDs). It has a strong presence in first line of defense' products such as Paracetamol, Ibuprofen and Metformin. Currently, company has eight manufacturing facilities spread over India, China & US. Company operate in 75 countries, with over 300 customers across the globe & about 60% of...
Number of MF schemes decreased from 28 to 17 in Sep 2025 qtr
More from Granules India Ltd.
Recommended